Distinct aerobic and hypoxic mechanisms of HIF-α regulation by CSN5

被引:61
作者
Bemis, L
Chan, DA
Finkielstein, CV
Qi, L
Sutphin, PD
Chen, XJ
Stenmark, K
Giaccia, AJ
Zundel, W
机构
[1] Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Biochem, Denver, CO 80262 USA
[3] Xiangya Hosp, Div Urol, Changsha, Peoples R China
[4] Stanford Univ, Program Canc Biol, Stanford, CA 94303 USA
[5] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94303 USA
[6] Univ Louisville, Dept Radiat Oncol, Louisville, KY 40202 USA
[7] Univ Louisville, Ctr Canc, Louisville, KY 40202 USA
关键词
D O I
10.1101/gad.1180104
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Mammalian oxygen homeostasis is dependent on the HIF family of transcription factors. The CSN subunit, CSN5, binds both the CODD of HIF-1alpha and the pVHL tumor suppressor. High CSN5 expression generates a pVHL-independent form of CSN5 that stabilizes HIF-1alpha aerobically by inhibiting HIF-1alpha prolyl-564 hydroxylation. Aerobic CSN5 association with HIF-1alpha occurs independently of the CSN holocomplex, leading to HIF-1alpha stabilization independent of Cullin 2 deneddylation. CSN5 weakly associates with HIF-1alpha under hypoxia, but is required for optimal hypoxia-mediated HIF-1alpha stabilization. These results indicate that CSN5 regulates aerobic as well as hypoxic HIF-1alpha stability by different mechanisms during oncogenesis.
引用
收藏
页码:739 / 744
页数:6
相关论文
共 11 条
  • [1] Jab1 interacts directly with HIF-1α and regulates its stability
    Bae, MK
    Ahn, MY
    Jeong, JW
    Bae, MH
    Lee, YM
    Bae, SK
    Park, JW
    Kim, KR
    Kim, KW
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (01) : 9 - 12
  • [2] Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1α
    Chan, DA
    Sutphin, PD
    Denko, NC
    Giaccia, AJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (42) : 40112 - 40117
  • [3] Investigating hypoxic tumor physiology through gene expression patterns
    Denko, NC
    Fontana, LA
    Hudson, KM
    Sutphin, PD
    Raychaudhuri, S
    Altman, R
    Giaccia, AJ
    [J]. ONCOGENE, 2003, 22 (37) : 5907 - 5914
  • [4] Retrovirus-delivered siRNA
    Devroe E.
    Silver P.A.
    [J]. BMC Biotechnology, 2 (1)
  • [5] von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF
    Hoffman, MA
    Ohh, M
    Yang, HF
    Klco, JM
    Ivan, M
    Kaelin, WG
    [J]. HUMAN MOLECULAR GENETICS, 2001, 10 (10) : 1019 - 1027
  • [6] Structural basis for the recognition of hydroxyproline in αIF-1α by pVHL
    Hon, WC
    Wilson, MI
    Harlos, K
    Claridge, TDW
    Schofield, CJ
    Pugh, CW
    Maxwell, PH
    Ratcliffe, PJ
    Stuart, DI
    Jones, EY
    [J]. NATURE, 2002, 417 (6892) : 975 - 978
  • [7] Jiang BH, 2001, CELL GROWTH DIFFER, V12, P363
  • [8] The von Hippel-Lindau tumor suppressor protein: new insights into oxygen sensing and cancer
    Kim, W
    Kaelin, WG
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 2003, 13 (01) : 55 - 60
  • [9] An intact NEDD8 pathway is required for Cullin-dependent ubiquitylation in mammalian cells
    Ohh, M
    Kim, WY
    Moslehi, JJ
    Chen, YZ
    Chau, V
    Read, MA
    Kaelin, WG
    [J]. EMBO REPORTS, 2002, 3 (02) : 177 - 182
  • [10] Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma
    Schulz, WA
    Elo, JP
    Florl, AR
    Pennanen, S
    Santourlidis, S
    Engers, R
    Buchardt, M
    Seifert, HH
    Visakorpi, T
    [J]. GENES CHROMOSOMES & CANCER, 2002, 35 (01) : 58 - 65